METHODS	Eligible patients with T-scores of the hip ( < -1.0 , but > -2.5 vs > -1.0 ) and negative bone scans were prospectively randomized to either zoledronic acid , 4mg , concurrently with the start of RT and then every six months for a total of 6 infusions ( Arm 1 ) or observation ( Arm 2 ) .\